Sanjay Trivedi
Intas eyes Teva’s oncology, women’s health divisions in Europe
Within a year of buying out Teva's UK and Ireland assets and breaking into the top 20 generics players club, Intas Pharmaceuticals is on...
top of page
Search
bottom of page